Although multiple studies have documented the role of SESN2 in hepatocellular carcinoma, non-small cell lung cancer, bladder cancer, and colon cancer [27,28,29,30], there are conflicting results regarding its expression in hepatocellular carcinoma [28,31]. This evidence concerns the gene SESN2 and urinary bladder carcinoma.